Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.3 DKK | -0.14% | +2.69% | +43.58% |
06-04 | Transcript : ALK-Abelló A/S - Analyst/Investor Day | |
06-03 | ALK Presents Positive Phase 3 Paediatric Trial Data Offering New Hope for Children with Respiratory Allergy | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALK-ABELLÓ A/S | Other Pharmaceuticals | -0.14% | +2.69% | +43.58% | +65.40% | +83.46% | 4.64B |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALK B Stock
- Charts ALK-Abelló A/S
- Comparison Chart